focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,096.00
Bid: 12,088.00
Ask: 12,092.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,090.00
High: 12,118.00
Low: 12,038.00
Prev. Close: 12,110.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Spain limits AstraZeneca coronavirus vaccine to over 60-year olds

Wed, 07th Apr 2021 23:14

(Recasts to focus on AstraZeneca)

MADRID, April 7 (Reuters) - Spain will only give
AstraZeneca's coronavirus vaccine to people over 60 years old
after European and British regulators found a potential link
between the shot and rare brain blood clots.

"The vaccination strategy is changing and from tomorrow only
over 60-year-olds will be vaccinated with AstraZeneca," Health
Minister Carolina Darias told a news conference late on
Wednesday following a meeting of regional health chiefs.

Darias said a decision would be taken on Thursday on whether
to administer the second round of the vaccine to people who had
already received their first dose.

The European Medicines Agency announced earlier it had
reports of 169 cases of the rare clotting disorder out of 34
million doses administered within Europe, roughly one for every
100,000 people under 60 vaccinated. Most occurred in women under
60 and within two weeks of injection. [nL1N2M01J1

Maria Jesus Lamas, director of Spain's drug regulator, said
that number was higher than expected, though very small:
"Despite the rarity of these side effects, the modification to
the technical guidance is important," Lamas said.

A summit of European Union health ministers failed to agree
on common guidance for the vaccine and the EMA said countries
should set their own regulations.

Spain's decision follows Italy recommending the shot only
for those over 60 and Britain said people under 30 should get an
alternative.

People lining up for a shot in Madrid earlier on Wednesday
vented frustration at constantly changing guidance for the
vaccine, which is subject to a patchwork of different rules
governing its use.

"Today has been a very distressing day because of all the
news coming from the European Medicines Agency," said Carmen
Ruiz after coming out of Atletico Madrid's Wanda football
stadium, now converted into a vaccine centre.

Though Spain is faring better than neighbouring France,
where rampant infections have pushed hospital admittance rates
to near five-month highs, the daily caseload has been increasing
for three weeks.

The health ministry registered 8,788 new cases, bringing the
total to 3.33 million. The death toll rose by 126 to 76,037.

Wary that increased social contact over Easter could trigger
a full-blown fourth wave, authorities in Catalonia, the Basque
Country and Aragon imposed fresh restrictions on movement.

(Reporting by Clara-Laeila Laudette, Guillermo Martinez, Elena
Rodriguez, Nathan Allen and Joan Faus, editing by Andrei Khalip
and Grant McCool)

More News
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.